Cancer News and Research

Latest Cancer News and Research

New theory for how stem cells decide whether to become liver or pancreatic cells

Harvard stem cell scientists have a new theory for how stem cells decide whether to become liver or pancreatic cells during development. A cell's fate, the researchers found, is determined by the nearby presence of prostaglandin E2, a messenger molecule best known for its role in inflammation and pain.

14 Feb 2014

Study reveals appearance-based video emphasizes teens to use sunscreen

After offering information about UV light and sun-protective behaviors, the two health-ed videos diverge: one describes the increased skin cancer risk of UV exposure and the other describes effects on appearance including wrinkles and premature aging.

14 Feb 2014

Researchers find unique role for p66Shc adaptor protein in regulating glucose and cell growth

A protein that has been known until recently as part of a complex communications network within the cell also plays a direct role in regulating sugar metabolism, according to a new study published on-line in the journal Science Signaling (February 18, 2014).

14 Feb 2014

FDA approves Biologics’ IMBRUVICA as oral agent for treatment of patients with CLL

Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

14 Feb 2014

New approach for treating leukemia

A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.

14 Feb 2014

Sarcopenia increases risk of sepsis risk in patients undergoing live donor liver transplantation

Japanese researchers have determined that sarcopenia—a loss of skeletal muscle mass—increases risk of sepsis and mortality risk in patients undergoing live donor liver transplantation.

14 Feb 2014

Indoor exposure to radon gas may cause of lung cancer

Pointing to startling statistics on lung cancer risks, child health and other experts in Canada are ramping up calls for families nationwide to test their homes for radon gas contamination.

14 Feb 2014

FDA-approved drug pregabalin effectively treats RLS symptoms with less side effects

A report in the Feb. 13 New England Journal of Medicine confirms previous studies suggesting that long-term treatment with the type of drugs commonly prescribed to treat restless leg syndrome (RLS) can cause a serious worsening of the condition in some patients.

14 Feb 2014

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

Prestige Care, Inc., and Prestige Senior Living L.L.C., leaders in exceptional senior living and skilled nursing and rehabilitation care, today announced that they are making plans to join with Carson Tahoe Health to expand quality senior care services and offer comprehensive memory care to Carson City residents and their families. As a first step in the relationship, the organizations will develop a community with 40 units for memory care services on the Carson Tahoe Specialty Medical Center campus. Construction will begin in 2014.

13 Feb 2014

EOS imaging system installed at Shriners Hospitals for Children in Philadelphia

EOS imaging, the pioneer in orthopaedic 2D/3D imaging, today announced the installation of the EOS imaging system at Shriners Hospitals for Children in Philadelphia. This fourth installation within the Shriners Hospitals for Children system, a group of hospitals focused on caring for children with neuromusculoskeletal conditions and other specialty healthcare, validates the adoption of EOS technology as the standard of care for imaging within the network.

13 Feb 2014

Researchers discover promising new approach for leukemia treatment

A group of researchers at the Institute for Research in Immunology and Cancer of Universit- de Montr-al discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. That gene, known as Brg1 is a key regulator of leukemia stem cells that are the root cause of the disease, resistance to treatment and relapse.

13 Feb 2014

Moderate-intensity exercise reduces stroke risk in women

Women don't need to run marathons or do intense aerobics to reduce their stroke risk. Moderate-intensity exercise - such as brisk walking or playing tennis -- may do the trick, according to research presented at the American Stroke Association's International Stroke Conference 2014.

13 Feb 2014

Agenus closes previously announced acquisition of 4-Antibody

Agenus Inc., a biopharmaceutical company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anti-cancer vaccines and adjuvants, today completed the previously announced acquisition of 4-Antibody AG, a private European-based biopharmaceutical company.

13 Feb 2014

DataArt reports record revenue of $40 million for 2013

DataArt, a leading custom software development firm serving select industries, today announced a record revenue of $40M for 2013, a 25% annual growth, with over 90 new client wins.

13 Feb 2014

FDA grants full approval of SYNRIBO for injection

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.

13 Feb 2014

Cancer News and Research

Latest Cancer News and Research

New theory for how stem cells decide whether to become liver or pancreatic cells

Study reveals appearance-based video emphasizes teens to use sunscreen

Researchers find unique role for p66Shc adaptor protein in regulating glucose and cell growth

FDA approves Biologics’ IMBRUVICA as oral agent for treatment of patients with CLL

New approach for treating leukemia

Sarcopenia increases risk of sepsis risk in patients undergoing live donor liver transplantation

Indoor exposure to radon gas may cause of lung cancer

FDA-approved drug pregabalin effectively treats RLS symptoms with less side effects

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

EOS imaging system installed at Shriners Hospitals for Children in Philadelphia

Researchers discover promising new approach for leukemia treatment

Moderate-intensity exercise reduces stroke risk in women

Agenus closes previously announced acquisition of 4-Antibody

DataArt reports record revenue of $40 million for 2013

FDA grants full approval of SYNRIBO for injection

Albert Einstein College professor receives AAAS 2013 Newcomb Cleveland Prize

Novogene purchases HiSeq X Ten sequencing system from Illumina

Study reveals that more than 14% of pregnant women are prescribed opioids for pain

Extracts from algae, rosemary and monk fruit could soon replace synthetic ingredients and food additives

Severe skin reactions during radiation therapy could be prevented by applying silicone dressing

Industry Focus eBook - Oncology (3rd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (3rd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in